By Fineline Cube China-based Jacobson Pharma Corporation (HKG: 2633), Ban Loong Holdings Ltd (HKG: 0030), and JBM (Healthcare) Limited (HKG: 2161) are set to establish a joint venture (JV) with a capital of HKD 6 million (USD 764,361). The companies will hold stakes of 20%, 60%, and 20% respectively. The JV aims to distribute licensed specialty drugs, developed healthcare products, and medical devices.
JV Structure and Ownership
Ban Loong Holdings Ltd will be the majority stakeholder with a 60% share, while Jacobson Pharma Corporation and JBM (Healthcare) Limited will each hold 20% stakes in the venture. This strategic partnership combines the resources and expertise of the three companies to enhance market reach and distribution capabilities in the healthcare sector.
Business Scope and Strategic Goals
The primary focus of the JV will be on the distribution of licensed specialty drugs, developed healthcare products, and medical devices. By integrating their respective strengths, the companies aim to expand their market presence and improve accessibility to quality healthcare products.-Fineline Info & Tech